First-line cemiplimab for locally advanced non-small cell lung cancer: Updated subgroup analyses from EMPOWER-Lung 1 and EMPOWER-Lung 3E. Kalinka,I. Bondarenko,M. Gogishvili,T. Melkadze,A. Baramidze,A. Sezer,T. Makharadze,S. Kilickap,M. Gumus,K. D. Penkov,D. Giorgadze,M. Ozguroglu, X. He,J-F. Pouliot,F. Seebach,I. Lowy,G. Gullo,P. RietschelJOURNAL OF THORACIC ONCOLOGY（2023）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
